[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3858 Enrolled Bill (ENR)]
H.R.3858
One Hundred Eighth Congress
of the
United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Tuesday,
the twentieth day of January, two thousand and four
An Act
To amend the Public Health Service Act to increase the supply of
pancreatic islet cells for research, and to provide for better
coordination of Federal efforts and information on islet cell
transplantation.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Pancreatic Islet Cell
Transplantation Act of 2004''.
SEC. 2. ORGAN PROCUREMENT ORGANIZATION CERTIFICATION.
Section 371 of the Public Health Service Act (42 U.S.C. 273) is
amended by adding at the end the following:
``(c) Pancreata procured by an organ procurement organization and
used for islet cell transplantation or research shall be counted for
purposes of certification or recertification under subsection (b).''.
SEC. 3. ANNUAL ASSESSMENT ON PANCREATIC ISLET CELL TRANSPLANTATION.
Section 429 of the Public Health Service Act (42 U.S.C. 285c-3) is
amended by adding at the end the following:
``(d) In each annual report prepared by the Diabetes Mellitus
Interagency Coordinating Committee pursuant to subsection (c), the
Committee shall include an assessment of the Federal activities and
programs related to pancreatic islet cell transplantation. Such
assessment shall, at a minimum, address the following:
``(1) The adequacy of Federal funding for taking advantage of
scientific opportunities relating to pancreatic islet cell
transplantation.
``(2) Current policies and regulations affecting the supply of
pancreata for islet cell transplantation.
``(3) The effect of xenotransplantation on advancing pancreatic
islet cell transplantation.
``(4) The effect of United Network for Organ Sharing policies
regarding pancreas retrieval and islet cell transplantation.
``(5) The existing mechanisms to collect and coordinate
outcomes data from existing islet cell transplantation trials.
``(6) Implementation of multiagency clinical investigations of
pancreatic islet cell transplantation.
``(7) Recommendations for such legislation and administrative
actions as the Committee considers appropriate to increase the
supply of pancreata available for islet cell transplantation.''.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.